Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer. Issue 4 (28th August 2019)

• Record Type: Journal Article
• Authors: Jiang, W; Verma, V; Haque, W; Moreno, A C; Koshy, M; Butler, E B; Teh, B S
• Is Part Of: Diseases of the esophagus. Volume 33:Issue 4(2020)
• Publication Date: 2019-08-28
• Subjects: chemotherapy -- esophageal cancer -- mortality -- radiation therapy -- surgery; Esophagus -- Diseases -- Periodicals; 616.32
• DOI: 10.1093/dote/doz073
• Languages: English
• ISSNs: 1120-8694

Abstract

SUMMARY: In efforts to better characterize incidence and predictors of 30- and 90-day mortality following operative versus nonoperative approaches for locally advanced esophageal cancer (EC), we conducted a novel investigation of a large, contemporary US database. The National Cancer Database was queried for newly-diagnosed T1–3N0–1 squamous cell or adenocarcinoma receiving surgical-based therapy (esophagectomy alone or preceded by chemotherapy and/or radiotherapy) versus definitive chemoradiotherapy (dCRT). Statistics included graphing cumulative incidences of mortality before and following propensity score matching (PSM), based on age-based intervals. Cox regression determined factors independently predictive of 30- and 90-day mortality. Of 15, 585 patients, 9, 278 (59.5%) received surgical-based therapy and 6, 307 (40.5%) underwent dCRT. In the unadjusted population, despite nonsignificant differences at 30 days (3.3% dCRT, 3.6% surgical-based), the dCRT cohort experienced higher 90-day mortality (11.0% vs. 7.5%, P < 0.001). Following PSM, however, dCRT patients experienced significantly lower 30-day mortality ( P < 0.001), with nonsignificant differences at 90 days ( P = 0.092). Surgical-based management yielded similar (or better) mortality as dCRT in ≤70-year-old patients; however, dCRT was associated with reduced mortality in subjects > 70 years old. In addition to the intervention group, factors predictive for 30- and 90-day mortality included age, gender, insurance status, facility type, comorbidity index, tumor location, histology, and T/N classification. In summary, surgical-based therapy for EC is associated with higher 30-day mortality, which becomes statistically similar to dCRT by 90 days. Differences between surgery and dCRT were most pronounced in patients > 70 years of age. These data may better inform shared decision-making between multidisciplinary providers and patients.